β¨ Medicine Distribution Consents
29 SEPTEMBER 2005
NEW ZEALAND GAZETTE, No. 165
4139
Provisional Consent to the Distribution of a New Medicine
Pursuant to section 23 of the Medicines Act 1981, the Minister of Health hereby provisionally consents to the sale, supply or use in New Zealand of the new medicine set out in the Schedule hereto:
Schedule
Product: Colgout
Active Ingredient: Colchicine 0.5mg
Dosage Form: Tablet
New Zealand Sponsor: Anspec New Zealand Limited
Manufacturer: Strides Arcolab Limited, Indlawadi Cross, Anekal Taluk, Bangalore, India
Note: This consent is valid for two years from the date of publication of this notice.
Dated this 26th day of September 2005.
DON MATHESON, Deputy Director-General, Public Health (pursuant to delegation given by the Minister of Health on 6 July 2001).
go6475
Renewal of Provisional Consent to the Distribution of a New Medicine
Pursuant to section 23 of the Medicines Act 1981, the Minister of Health hereby provisionally consents to the sale, supply or use in New Zealand of the new medicine set out in the Schedule hereto:
Schedule
Product: Actigall
Active Ingredient: Ursodeoxycholic acid 300mg
Dosage Form: Capsule
New Zealand Sponsor: Novartis New Zealand Limited Pharmaceutical Sector
Manufacturer: Watson Laboratories Inc, Carmel NY, United States of America
Note: This consent is valid for two years from 7 September 2005.
Dated this 26th day of September 2005.
DON MATHESON, Deputy Director-General, Public Health (pursuant to delegation given by the Minister of Health on 6 July 2001).
go6471
Consent to the Distribution of New Medicines
Pursuant to section 20 of the Medicines Act 1981, the Minister of Health hereby consents to the distribution in New Zealand of the new medicines set out in the Schedule hereto:
Schedule
Product: Desmopressin PH&T
Active Ingredient: Desmopressin acetate 0.6mg equivalent to desmopressin 0.089mg/mL
Dosage Form: Nasal spray solution
New Zealand Sponsor: AFT Pharmaceuticals Limited
Manufacturer: MIPHARM S.p.A, Milano, Italy
Product: m-cefazolin
Active Ingredient: Cephazolin sodium 2.096g equivalent to cefazolin 2g
Dosage Form: Powder for injection
New Zealand Sponsor: Multichem NZ Limited
Manufacturer: Laboratorio Reig Jofre SA, Sant Adria de Besos, Barcelona, Spain
Product: m-Cefazolin
Active Ingredient: Cephazolin sodium 1.048g equivalent cefazolin 1g
Dosage Form: Powder for injection
New Zealand Sponsor: Multichem NZ Limited
Manufacturers: Laboratorio Reig Jofre SA, Sant Adria de Besos, Barcelona, Spain
Laboratorio Reig Jofre SA, Sant Joan Despi, Barcelona, Spain
Product: m-cefazolin
Active Ingredient: Cephazolin sodium 524mg equivalent to cefazolin 500mg
Dosage Form: Powder for injection
New Zealand Sponsor: Multichem NZ Limited
Manufacturers: Laboratorio Reig Jofre SA, Sant Adria de Besos, Barcelona, Spain
Laboratorio Reig Jofre SA, Sant Joan Despi, Barcelona, Spain
Product: m-Fluconazole
Active Ingredient: Fluconazole 100mg
Dosage Form: Capsule
New Zealand Sponsor: Multichem NZ Limited
Manufacturer: Pharmathen SA, Pallini, Attikis, Greece
Next Page →
Online Sources for this page:
VUW Te Waharoa —
NZ Gazette 2005, No 165
Gazette.govt.nz —
NZ Gazette 2005, No 165
β¨ LLM interpretation of page content
π₯
Consent to the Distribution of New Medicines
(continued from previous page)
π₯ Health & Social Welfare26 September 2005
Medicines, Distribution, Consent, Medicines Act 1981
- DON MATHESON, Deputy Director-General, Public Health
π₯ Provisional Consent to the Distribution of a New Medicine
π₯ Health & Social Welfare26 September 2005
Medicines, Provisional Consent, Distribution, Colchicine
- DON MATHESON, Deputy Director-General, Public Health
π₯ Renewal of Provisional Consent to the Distribution of a New Medicine
π₯ Health & Social Welfare26 September 2005
Medicines, Provisional Consent, Renewal, Ursodeoxycholic acid
- DON MATHESON, Deputy Director-General, Public Health